Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A Three-View System for CRISPR-Cas12a crRNA Activity Ranking: When to Ensemble, When Context Matters More

Created on 10 Nov 2026

Authors

Deng, T., Lin, Z., Lam, H., Xu, S.

Abstract

CRISPR-Cas12a assays require effective crRNA selection, but experimentally screening all possible candidates is costly. We developed TriCasRank, a ranking model that combines sequence features with EasyDesign reference mapping and activity summaries from related training records. Historical summaries were calculated within each training fold to avoid information leakage. In five-fold target-grouped cross-validation using out-of-fold predictions, TriCasRank improved the Spearman correlation from 0.741 for the sequence-only ensemble to 0.821 (paired difference, 0.080; 95% target-group bootstrap interval, 0.072 to 0.090). However, its performance was comparable to that of a strong sequence-plus-mapping XGBoost model (SCC, 0.822; paired difference, -0.001; 95% interval, -0.007 to 0.005). Separate perturbation analyses supported the predictive value of mapping and historical features, although their effect sizes were not directly comparable because they were evaluated using different model configurations. Prediction errors remained larger at the extremes of the activity distribution. Performance also became less stable when template identities were separated between training and evaluation. TriCasRank may therefore be useful for ranking candidates represented within the EasyDesign-derived domain, but evaluation on an independent experimental cohort is still needed.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 10 Nov 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement